Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0004 Transporter Info | ||||
| Gene Name | ABCG2 | ||||
| Transporter Name | Breast cancer resistance protein | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Rosuvastatin Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 446157 | ||||
| Docking Score | -12.386 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C22H28FN3O6S | ||||
| Molecular Weight | 481.5 | ||||
| Canonical SMILES |
CC(C)C1=NC(=NC(=C1/C=C/[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
|
||||
| InChI |
InChI=1S/C22H28FN3O6S/c1-13(2)20-18(10-9-16(27)11-17(28)12-19(29)30)21(14-5-7-15(23)8-6-14)25-22(24-20)26(3)33(4,31)32/h5-10,13,16-17,27-28H,11-12H2,1-4H3,(H,29,30)/b10-9+/t16-,17-/m1/s1
|
||||
| InChIKey | BPRHUIZQVSMCRT-VEUZHWNKSA-N | ||||
| Pharmaceutical Properties | Xlogp | 1.6 | Rotatable Bond Count | 10 | |
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 10 | ||
| Xenobiotic Name | Daunorubicin Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 30323 | ||||
| Docking Score | -12.191 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C27H29NO10 | ||||
| Molecular Weight | 527.5 | ||||
| Canonical SMILES |
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O
|
||||
| InChI |
InChI=1S/C27H29NO10/c1-10-22(30)14(28)7-17(37-10)38-16-9-27(35,11(2)29)8-13-19(16)26(34)21-20(24(13)32)23(31)12-5-4-6-15(36-3)18(12)25(21)33/h4-6,10,14,16-17,22,30,32,34-35H,7-9,28H2,1-3H3/t10-,14-,16-,17-,22+,27-/m0/s1
|
||||
| InChIKey | STQGQHZAVUOBTE-VGBVRHCVSA-N | ||||
| Pharmaceutical Properties | Xlogp | 1.8 | Rotatable Bond Count | 4 | |
| Hydrogen Bond Donor Count | 5 | Hydrogen Bond Acceptor Count | 11 | ||
| Xenobiotic Name | Atazanavir Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 148192 | ||||
| Docking Score | -12.14 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C38H52N6O7 | ||||
| Molecular Weight | 704.9 | ||||
| Canonical SMILES |
CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC
|
||||
| InChI |
InChI=1S/C38H52N6O7/c1-37(2,3)31(41-35(48)50-7)33(46)40-29(22-25-14-10-9-11-15-25)30(45)24-44(43-34(47)32(38(4,5)6)42-36(49)51-8)23-26-17-19-27(20-18-26)28-16-12-13-21-39-28/h9-21,29-32,45H,22-24H2,1-8H3,(H,40,46)(H,41,48)(H,42,49)(H,43,47)/t29-,30-,31+,32+/m0/s1
|
||||
| InChIKey | AXRYRYVKAWYZBR-GASGPIRDSA-N | ||||
| Pharmaceutical Properties | Xlogp | 5.6 | Rotatable Bond Count | 18 | |
| Hydrogen Bond Donor Count | 5 | Hydrogen Bond Acceptor Count | 9 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.